NOVOVAX vaccine

Photo: Indian Express

India Allows Export Of 20 Mln "Novavax" Vaccine To Indonesia: Sources

India has approved the shipment of 20 million doses of the Novavax (NVAX.O) COVID-19 vaccine developed by the Serum Institute of India (SII) to Indonesia, according to reports. Further, the government has also decided to allow 10 million doses of Covishield, also manufactured by SII, to be exported on the global vaccine-sharing program. As per sources, the government has no plans to place an order for Merck & Co.'s COVID-19 pill.

Fri, 19 Nov 2021 - 09:08 PM / by SAM RAHUL RAJASHEKHAR

Tags: Novavax, Serum Institute of India, India, Indonesia, Vaccination

Courtesy: Reuters

Novavax vaccine representative image

Photo: Live Mint

Novavax COVID Vaccine Likely To Be Approved For Emergency Use, Awaits WHO approval

Novavax reportedly has completed the process of submitting the necessary documents of "NVX-CoV2373", a protein-based COVID-19 vaccine to the World Health Organisation's (WHO) emergency use list. Moreover, the company is also expecting regulators in… read-more

Fri, 05 Nov 2021 - 06:35 PM / by SAM RAHUL RAJASHEKHAR

Tags: covid 19, Covid Vaccination, Novavax, WHO, India

Courtesy: Reuters

Adar Poonawalla

Photo: The Economic Times

Serum Institue Plans To Launch Covovax By August: Adar Poonawalla 

The Serum Institute of India is planning to launch another COVID-19 vaccine 'Covovax' by August 2021. Developed by Novavax, an American vaccine maker, the Covovax will be stockpiled by the SII, for its testing on the Indian population, starting from April. Speaking at the Bloomberg Equity Index, SII CEO Adar Poonawalla said Covovax distribution will start after receiving the government’s nod. Poonawalla added that the global COVAX facility is… read-more

Thu, 18 Mar 2021 - 03:00 PM / by Nikita Thakur

Tags: Novavax, Adar Poonawalla, SII, Covid-19 Vaccine, COVAX, WHO

Covid -19 Vaccine

Photo: Indian Express

SII Hopeful To Launch Its 2nd Vaccine 'COVOVAX' By June

The Serum Institute of India (SII) chief Adar Poonawalla on January 30 announced of hopefully launching ‘COVOVAX’ as the second COVID-19 vaccine in June 2021. Poonawalla also claimed that the Novavax vaccine that has partnered with the US is currently undergoing trials and has shown excellent efficiency. While DCGI approved vaccines Covishield and Covaxin were used in India, the COVOVAX would become the third vaccine developed by India if… read-more

Sat, 30 Jan 2021 - 07:48 PM / by Sakshi Teresa Emmanuel

Tags: Serum Institute of India, Adar Poonawalla, Covovax, Novavax, Coronavirus, Covid-19 Vaccine

Courtesy: Zee News

Novavax

Photo: Quartz

SII Awaits Govt Approval To Conduct Trials Of Novavax COVID Vaccine

The Serum Institute of India has applied to the Drugs Controller General of India seeking permission to conduct domestic trials of ‘Novavax’ coronavirus vaccine. Reportedly, the US-based company claimed that Novavax showed 89.3% and 60% effectiveness during the trials in the UK and Africa respectively. Earlier, Novavax and SII collaborated to produce 2 billion vaccine doses. Besides, Novavax has received around $388 million from the Coalition… read-more

Fri, 29 Jan 2021 - 01:19 PM / by Nikita Thakur

Tags: Novavax, SII, Serum Institute of India, DCGI

Courtesy: Live Mint